HIV 1 GENOTYPE DRUG RESISTANCE TEST

HIV 1 Genotype Drug Resistance Test is an advanced molecular diagnostic test used to identify genetic mutations in the Human Immunodeficiency Virus Type 1 (HIV-1) that may cause resistance to antiretroviral medications. The test analyzes specific regions of the HIV genome and helps physicians determine which medications are likely to be effective or ineffective for an individual's treatment.

Drug resistance can develop when HIV mutates over time, particularly in patients receiving antiretroviral therapy (ART). Identifying resistance-associated mutations is critical for selecting the most effective treatment regimen, improving viral suppression, and reducing the risk of treatment failure.

Benefits of the Test

• Detects HIV drug resistance mutations.
• Supports personalized antiretroviral therapy selection.
• Helps identify causes of treatment failure.
• Improves treatment effectiveness and outcomes.
• Guides optimization of HIV management.
• Provides detailed genetic analysis of HIV strains.
• Supports evidence-based clinical decisions.
• Helps prevent unnecessary medication exposure.

Why Doctors Recommend This Test

Doctors recommend HIV 1 Genotype Drug Resistance testing for patients with virological failure, rising viral loads, inadequate response to antiretroviral therapy, newly diagnosed HIV infection in selected cases, or before changing treatment regimens.

The test helps identify resistance mutations and supports selection of the most effective antiretroviral medications.

Preparation Before Test

• No fasting is generally required.
• A blood sample is collected for testing.
• Inform your doctor about current antiretroviral medications.
• Provide previous HIV viral load and treatment history.
• Follow all sample collection instructions carefully.
• Ensure timely specimen submission to the laboratory.

Normal Reporting Time

Most HIV 1 Genotype Drug Resistance Test reports at Focus Diagnostics are initiated within 2–3 hours for specimen processing and molecular workflow setup. Comprehensive sequencing, mutation analysis, resistance interpretation, and final reporting generally require several working days depending on laboratory protocols and quality assurance procedures.

Who Should Take This Test?

This test may be recommended for:

• Patients with HIV treatment failure.
• Individuals with increasing HIV viral load.
• People requiring changes in antiretroviral therapy.
• Patients with suspected drug-resistant HIV.
• Individuals with incomplete viral suppression.
• Newly diagnosed HIV patients in selected clinical situations.
• Patients undergoing specialist HIV management.
• People requiring personalized treatment planning.

Detailed Information

Human Immunodeficiency Virus (HIV) is a rapidly evolving virus that can develop genetic mutations over time. Some mutations may reduce the effectiveness of specific antiretroviral medications, resulting in drug resistance. When resistance develops, previously effective medications may no longer adequately suppress viral replication.

HIV genotype drug resistance testing evaluates key regions of the HIV genome associated with resistance to major classes of antiretroviral drugs, including nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), and other targeted therapies depending on the testing methodology used.

The test uses advanced molecular sequencing and bioinformatics analysis to identify clinically significant mutations. The detected mutations are compared against established resistance databases and interpreted according to internationally recognized guidelines.

Genotypic resistance testing plays a crucial role in modern HIV care. It helps physicians understand why treatment may not be working effectively and assists in selecting alternative medications that remain active against the patient's viral strain.

The test is particularly important when viral load levels increase despite ongoing therapy, indicating possible treatment failure. It may also be considered in newly diagnosed patients to identify transmitted drug resistance before initiating therapy.

Results are typically reported with a detailed interpretation describing resistance patterns and potential medication susceptibility. The findings help clinicians create individualized treatment plans aimed at achieving long-term viral suppression.

At Focus Diagnostics, HIV 1 Genotype Drug Resistance Testing is performed using advanced molecular diagnostic platforms, validated sequencing technologies, and stringent quality assurance standards to provide accurate, reliable, and clinically meaningful HIV resistance analysis.